3 results
Approved WMORecruiting
The objective of this prospective, observational study is to ensure the safety and the wellbeing of subjects treated with the NEVO* SES.
Not approvedWill not start
The main objective of this pilot study is to evaluate feasibility, experienced effects and side effects of LLLT, in relation to the administered dose to be able to detect an appropriate dose (intensity of laser) in patients with non-allergic…
Approved WMORecruiting
To evaluate the efficacy and safety of tucatinib in combination with trastuzumab and mFOLFOX6 in comparison to mFOLFOX6 given with or without either bevacizumab or cetuximab as first-line (1L) treatment in adults with HER2 positive (HER2+)…